By Scott D. Weingart, MDScienceMedicineHealth & Fitness
Download on the App Store

episodes

  • EMCrit 277 – COVID Pulmonary Physiology with Martin Tobin
    [featimage]

    Today on the podcast, I interview Martin Tobin on 3 papers he has recently written on COVID pulmonary physiology.
    Martin Tobin

    * Praise for Dr. Tobin
    * Bio Page

     
    Caution about Early Intubation in COVID-19
    p-SILI
    From 2 studies, 1 on sheep breathing with a human-equivalent Vt of 502 ml

    2nd study was observational with a questionable connection to Vt--it was confounded by a number of other factors
    Absence of Obtundation
     
    L vs. H Subtypes
     
    Physio Diversion - Looking for the Patient that needs more Inspiratory Flow

    * Tobin Vent Review in NEJM



     
    Basing Respiratory Management of COVID-19 on Physiological Principles
    Tachypnea in Isolation is Not an Indication for Intubation
    Not indicative of increased WOB
    Avoiding Intubation with NIPPV
    Correlation of saturation with a host of other evils, but it is possible that the saturation is merely a marker--similar to pH. Vicious cycle of shunt, low SvO2, encephalopathy, decreased resp. drive. COVID has been different, with decreased saturation without the horrible lung injury that normally accompanies it. We are also used to patient discomfort from the disease causing the hypoxemia. Retained good compliance. We have not seen the isolated hypoxemia of COVID in many situations before.

     
    The Baffling Case of Silent Hypoxemia
    Happy Hypoxemia vs. Silent Hypoxemia
    Dr. Tobin defines silent hypoxemia as PaO2 < 60 mmHg with a PaCO2 >39 mmHg (as a PaCO2 < =39) blunts the dyspneic response to hypoxemia

    Why don't they have dyspnea vs. why do they have such severe hypoxemia unaccompanied by the degree of standard badness that normally accompanies it

    They do not crump

    They don't develop multi-organ
    Dyspnea
    Purely subjective

    Advanced age and diabetes may blunt dypsnea

    Increase in 10 of PaCO2 causes extreme air hunger

    Increase Ve when PaO2 <60, but severe hypoxemia elicits increase in ventilation only when PaCO2 > 39 mmHg [32539537]
    Definition of Hypoxemia
    Do we need to factor in FiO2? Dr. Tobin and I say no!

    I define by pulse ox or (PaO2), doesn't matter how much O2. e.g. "He is still hypoxemic despite being placed on NRB."
    When does Hypoxemia Become Dangerous?
     
    Pulse Ox Inaccuracy
     
    OxyHemoglobin Dissociation Curve Shifts
    Fever shifts to the right, Decreased CO2 shifts left
    Mechanism of Silent Hypoxemia
    ACE2 is expressed in the carotid body and may be partially to blame
    COVID breaks our Heuristics
    Heuristic representation of how bad their lung disease actually is. Projecting expected course...

    COVID first disease that unlinks it
    Now on to the Podcast...
    33 min
  • EMCrit 276 – The Rapid Code Status Conversation with Kei Ouchi
    [featimage]

    Today, I am joined by Kei Ouchi to disucss rapid code status discussions in Emergency Medicine and Critical Care. I came across Kei after he put up an amazing post on ALIEM with his co-author Naomi George. Conversation is the essence of palliative care--we need to be experts at them.
    Kei Ouchi, MD
    Kei Ouchi is an assistant professor of emergency medicine at the Brigham and Women's Hospital in Boston. He splits his time between EM and palliative care research. [@KeiO97]
    Kei's and Naomi George's Guide to Rapid Code Status Conversations

    More to Read

    * ALIEM Post
    * Prognosis after intubation study by Kei
    * Long-term prognosis after MV (Kei's new study)
    * Functional trajectories of older adults after critical illness
    * Worse than dying
    * How patients experience LTACH
    * Median survival is 8 months if older adults are transferred to LTACH

     
    How Kei Trained in Palliative Care Conversations
    Scott, I realized I’ve never told you anything about how I trained in palliative care communications skills. I keep a record of difficult communication cases from my practice, and I regularly hire actors/role play the encounters with Susan Block (mentor) to get coaching since 2014. She is a master communicator and has been teaching this internationally for the last 35 years. I also completed the following courses and now teach Vital Talk to our trainees with palliative care folks.

    * Vital Talk
    * Harvard Pall Care Course

    Vital Talk is adapted to EM by Corita Grudzen, who is now running a large, national study to see if this makes a difference in patient outcomes.

    My ED code status conversation guide is an adaptation of the original Serious Illness Conversation Guide created by Susan Block:

     



     


    Kei's Newest Article

    * Kei New Article

    Now on to the Podcast:
    35 min
  • EMCrit 275 – NeuroCritical Care with Neha Dangayach
    [featimage]

    Today on the podcast, we discuss Neuro-Emergencies and NeuroCritical Care with Neha Dangayach. This is a wide-ranging conversation that you will truly enjoy.
    Neha Dangayach
    Neha is joining the EMCrit team!!!!!!

    Neha S. Dangayach MD, MSCR is an Assistant Professor of Neurology and Neurosurgery. Dr. Dangayach serves as the Director of Neuroemergencies Management and Transfers (NEMAT) for the Mount Sinai Health System, Neurocritical Care Fellowship Director and Research Co-Director for the Institute for Critical Care Medicine (ICCM). She is also a Co-Director of the Mount Sinai Hospital’s busy NSICU and collaborates with a compassionate team to provide world-class patient-centered Neurocritical Care. She leads the Mount Sinai Critical Care Resilience Program (MSCCRP), a multidisciplinary program including intensivists, nursing, social workers, physical, occupation and speech therapists, chaplains, nutritionists among others. Several projects under this program seek to help patients and families cope with ICU recovery. Her research focuses on resilience, spirituality and recovery in critical care; inter-hospital transfers for neuroemergencies and social media in medicine.
    Topics of Discussion with Time Stamps

    Neha's Slides

    * Neurocrit Care Stony Brook Grand Rounds

    Neuro-Emergency Management and Transfer (NEMAT) Service


     
    Tele-Stroke
    Video the CT with phone

    2 person job

    scroll through every image of axial head ct q 2 seconds

    Scroll through CTA MIPs, axial and coronal (sag is a bonus)

     
    ICH
    Blood Pressure
    Specify how often to cycle BP cuff

    Ischemic Stroke
     
    Who to Intubate and Neuroprotective Intubation

    * LAMW: The Neurocritical Care Intubation

     
    Which Osmotic Agent for ICP

    * Recently Published Guidelines

    Platelet Reversal
    Recent paper shows no benefit from PLTs or dDAVP in non-neurosurg bleeds [10.1097/CCM.0000000000004348]
    Status Epilepticus
    Choice of 2nd Line Agent
    Keppra 60mg/kg (1/2 the dose in ESRD)
    General Anesthetic of Choice is Midazolam
    0.2 mg/kg bolus

    start infusion 0.2 mg/kg/hr

    titrate up every 5 minutes

    max 2.9 mg/kg/hr

    when getting close to 1mg/kg/hr, give ketamine 1mg/kg followed by 1 mg/kg/hr

    Cirrhotics, get propofol
    Now on to the Podcast...
    1 hr 15 min
  • EMCrit 274 – Team Leadership with Cliff Reid


    Team leadership is hard [duh]. Teaching it to our trainees is even tougher. When you work in a team of true experts with established implicit communication, things just flow--giving the the team leader the impression that they actually know what the hell they are doing. The mark of a good team leader is how they handle a less than ideal team. I found a true master to interview on the topic of team leadership--friend of the show, Cliff Reid.
    Attitudinal Choices

    * Authoritative vs. empowering
    * Be Aware that many of us are helped or hurt by implicit biases

    Gender bias paper

    * Ju et al. Effect of Professional Background and Gender on Residents’ Perceptions of Leadership. Academic Medicine. 2019 Nov;94:S42–7.

    Prep and Prebrief

    * Relational Coordination by Purdy et al.

    from Purdy et al.
    Where to Stand

    * Foot of the bed in the opinion of Cliff and me

    Zero Point Survey (ZPS)

    * Cliff's Video on ZPS
    * Perform STEP at the beginning then UP for team recaps

    Recap / SitRep / Updates-Priorities

    * What am I missing here?

    How to Lead from the Follower Slot

    * Presupposition
    * Pacing and Leading
    * Play to their ego

    [easyazon_image align="none" height="160" identifier="006124189X" locale="US" src="https://m.media-amazon.com/images/I/51gysFA30GL._SL160_.jpg" tag="emcrit-20" width="105"]
    Drive by Voice / Fly by Voice

    * Commentary Driving

    Eyes On / Eyes Off


    Sydney HEMS Team Communication Videos
    More from Cliff on EMCrit

    * How to Be a Hero with Cliff Reid
    * Making Things Happen with Cliff Reid
    * Mind of the Resuscitationist with Cliff Reid
    * Cliff Reid's Own the Resus Room

    Additional Reading

    * Resus Communication
    * Hicks Human Factors for Teams Summary from Simulcast
    * Hicks Fog of War
    * Another of those duh studies, but it had to be done -- No difference between EM and surgery resident team leading for trauma
    * ABCs of Team Leadership from Regions
    * Brindley on followership

    Post Publication Peer Review from Iain Beardsell
    Chaps,

    I really enjoyed the podcast, and having learnt first hand from Cliff I hope I practic...
    52 min
  • EMCrit Wee – A Theoretical Model of the Pathophysiology of COVID-19 with Farid Jalali (Not a Single Thing Verified–Pure Musings)
    Today on the podcast, my guest lays out a theoretical framework for the pathophysiology of the lung effects of COVID-19.
    Farid Jalali
    Dr. Farid Jalali received his Medical Degree from West Virginia University School of Medicine in 2012. He completed his postgraduate training in Gastroenterology at the University of California, Irvine Medical Center in 2018. Dr. Jalali has had extensive training and experience in diagnosing and treating a broad spectrum of GI and Liver disorders. He has a special focus on cancer prevention and spends a great deal of time educating and helping patients on how to prevent cancers in the GI tract and Liver. [@farid__jalali]

    Pathophysiology

    Potential Treatments

     
    Slides from the Presentation

    * Farid Jalali COVID-19 Pathophys

    Take Home Points from the Talk

    * Early endothelial stabilization, before hypoxia sets in, is key to prevent SARS-CoV-2 induced, excess Angiotensin II mediated, intense alveolar capillary vasoconstriction as well as the concomitant pro-inflammatory, pro-thrombotic endothelial milieu, all of which form the basis of lung
    injury in COVID19.
    * Once hypoxia sets in, supportive care should include early and aggressive endothelial stabilization interventions, properly dosed anticoagulation to prevent lung microvascular thrombi, HFNC, and awake prone position to redistribute flow away from the forming dorsal-predominant intrapulmonary shunts.
    * Alveolar capillary microvascular thrombi are not a pre-requisite for the severe lung injury in COVID19, but are a clear step in the wrong direction if allowed to be formed.
    * Lung's natural and physiologic protective response to SARS-CoV-2 induced alveolar capillary vasoconstriction and dead-space ventilation is characterized by alveolar hypocapnic bronchoconstriction at the level of the alveolar ducts to reduce a harmful alveolar expansion in these affected capillaries.
    * Naturally, unaffected capillaries and corresponding alveoli will have a higher redistribution of ventilation, will exchange more CO2 into alveolar space, and will therefore have hypercapnic bronchodilation.
    * This redistribution keeps the lung compliance preserved in the initial lung injury characterized mainly by dead-space ventilation, forming intrapulmonary shunts, without significant interstitial or alveolar edema.
    * Compensatory lower inspiratory volumes characterize the patient's response, associated with higher respiratory rate, and "shallow rapid breaths" without distress. [this has not been my experience--EMCrit]
    * This lower inspiratory volume is needed to prevent expansion of alveoli in the affected vasculopathic areas, as inappropriate expansion compounds the vasoconstriction in these affected alveolar capillaries.
    * This will result in a compensatory tendency to develop hypocapnea on blood gas analysis, often concomitant with hypoxia as intrapulmonary shunts also begin to form as lung injury progress.
    * Higher lung volumes, and positive pressure ventilation, disturb the fine balance maintained physiologically in the ventilatory redistribution pattern of the COVID1 9 lung, between high V/Q mismatch areas (poor perfusion, compensatory reduced ventilation to protect against the vasculopathy) and the compensating lower V /Q areas that safely receive higher ventilation in return.
    * Therefore, mechanical ventilation may result in worsening of dead-space ventilation by constricting alveolar cap...
    56 min
  • EMCrit 273 – Inhaled Pulmonary Vasodilators & Q&A with Sara Crager


    This episode continues on from last time's talk by Sara Crager on Right Ventricular Failure. This is a Q&A session with a focus on inhaled pulmonary vasodilators.
    Nitric Oxide
    Sara likes it through ETT or Hi-Flo NC (can also be done through BIPAP)
    Start at 20 ppm
    See results within 5-10 minutes
    Monitor with CVP
    Problems

    * Nitric Dioxide (NO2) may be formed which can lead to pulmonary edema or even alveolar hemorrhage.
    * MetHb can be formed and some people do routine monitoring for this dyshemoglobinemia.

    Additional Resources

    * PulmCrit- Inhaled NO for submassive PE: iNOPE or iYEP?
    * Review Article on Inhaled NO

     
    Epoprostenol (Flolan)
    May be more complicated to set-up

    go back to marker 5

    Epoprostenol @ 0.05 mcg/kg/min

    Must have filters on the circuit

    * Review Article on Inhaled EpoProst

     
    Milrinone
    Get the vial, you want 1 mg/ml with 15 mls in vial

    5 ml (5 mg) q 6 hours (According to Dr. Crager--may be more frequent if symptoms rebound (down to q 3 hrs))

    Ideally use ultrasonic nebulizer

    onset ~15 minutes

    Must have filters on circuit

    LVOTO & RVOTO contraindication for the milrinone

     

    respigard!!!

    aeroneb pro

    must have filters on vent

    from Andre Denault Lecture
    Additional Resources

    * Inhaled Pulmonary Vasodilator Therapy for Management of Right Ventricular Dysfunction after Left Ventricular Assist Device Placement and Cardiac Transplantation




    * A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients



     
    Intratracheal Milrinone Bolus for a Crashing Patient
    50-80 mcg/kg or 5 mg (1/2 a bolus is also used by some)

    onset 4-5 minutes

    from the amazing Hospitalist & the Resuscitationist Lecture 2019 by Andre Denault

     
    Nitro
    Need conc. of 1 mg/ml (standard bottle is 200 mcg/ml)

    Doses in studies range from 2.5-25 mcg/kg/min for 10 minutes or 50 ug/kg total given over 8 minutes (perhaps easiest to put 4-5 mg in neb and let it run)

    * PulmCrit- Nebulized nitroglycerin: The stealth pulmonary vasodilator hiding under your nose?



    Photo by Valeriia Bugaiova on Unsplash
    Now on to the Podcast...
    27 min